120 related articles for article (PubMed ID: 28078913)
41. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
[TBL] [Abstract][Full Text] [Related]
42. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK
Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812
[TBL] [Abstract][Full Text] [Related]
43. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
Elbialy NS; Fathy MM; Khalil WM
Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells.
Thelen P; Wuttke W; Jarry H; Grzmil M; Ringert RH
J Urol; 2004 May; 171(5):1934-8. PubMed ID: 15076315
[TBL] [Abstract][Full Text] [Related]
45. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L
J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459
[TBL] [Abstract][Full Text] [Related]
46. The Effect of Chrysin Loaded PLGA-PEG on Metalloproteinase Gene Expression in Mouse 4T1 Tumor Model.
Mohammadi Z; Sharif Zak M; Seidi K; Barati M; Akbarzadeh A; Zarghami N
Drug Res (Stuttg); 2017 Apr; 67(4):211-216. PubMed ID: 28166590
[TBL] [Abstract][Full Text] [Related]
47. Co-Delivery of Curcumin and Chrysin by Polymeric Nanoparticles Inhibit Synergistically Growth and hTERT Gene Expression in Human Colorectal Cancer Cells.
Lotfi-Attari J; Pilehvar-Soltanahmadi Y; Dadashpour M; Alipour S; Farajzadeh R; Javidfar S; Zarghami N
Nutr Cancer; 2017; 69(8):1290-1299. PubMed ID: 29083232
[TBL] [Abstract][Full Text] [Related]
48. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
[TBL] [Abstract][Full Text] [Related]
49. Polymeric-gold nanohybrids for combined imaging and cancer therapy.
Topete A; Alatorre-Meda M; Villar-Alvarez EM; Carregal-Romero S; Barbosa S; Parak WJ; Taboada P; Mosquera V
Adv Healthc Mater; 2014 Aug; 3(8):1309-25. PubMed ID: 24764284
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of the cancer-associated TASK 3 channels by magnetically induced thermal release of Tetrandrine from a polymeric drug carrier.
Shi C; Thum C; Zhang Q; Tu W; Pelaz B; Parak WJ; Zhang Y; Schneider M
J Control Release; 2016 Sep; 237():50-60. PubMed ID: 27374629
[TBL] [Abstract][Full Text] [Related]
51. TPGS2k/PLGA nanoparticles for overcoming multidrug resistance by interfering mitochondria of human alveolar adenocarcinoma cells.
Wang DF; Rong WT; Lu Y; Hou J; Qi SS; Xiao Q; Zhang J; You J; Yu SQ; Xu Q
ACS Appl Mater Interfaces; 2015 Feb; 7(7):3888-901. PubMed ID: 25644220
[TBL] [Abstract][Full Text] [Related]
52. Preparation, Characterization and Cytotoxicity of Silibinin- Containing Nanoniosomes in T47D Human Breast Carcinoma Cells.
Amiri B; Ebrahimi-Far M; Saffari Z; Akbarzadeh A; Soleimani E; Chiani M
Asian Pac J Cancer Prev; 2016; 17(8):3835-8. PubMed ID: 27644625
[TBL] [Abstract][Full Text] [Related]
53. Characterisation, cytotoxicity and apoptosis studies of methotrexate-loaded PLGA and PLGA-PEG nanoparticles.
Afshari M; Derakhshandeh K; Hosseinzadeh L
J Microencapsul; 2014; 31(3):239-45. PubMed ID: 24124881
[TBL] [Abstract][Full Text] [Related]
54. PEG-detachable lipid-polymer hybrid nanoparticle for delivery of chemotherapy drugs to cancer cells.
Du JB; Song YF; Ye WL; Cheng Y; Cui H; Liu DZ; Liu M; Zhang BL; Zhou SY
Anticancer Drugs; 2014 Aug; 25(7):751-66. PubMed ID: 24590167
[TBL] [Abstract][Full Text] [Related]
55. Genistein-loaded nanoparticles of star-shaped diblock copolymer mannitol-core PLGA-TPGS for the treatment of liver cancer.
Wu B; Liang Y; Tan Y; Xie C; Shen J; Zhang M; Liu X; Yang L; Zhang F; Liu L; Cai S; Huai D; Zheng D; Zhang R; Zhang C; Chen K; Tang X; Sui X
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():792-800. PubMed ID: 26652434
[TBL] [Abstract][Full Text] [Related]
56. Magnetic-core-based silibinin nanopolymeric carriers for the treatment of renal cell cancer.
Takke A; Shende P
Life Sci; 2021 Jun; 275():119377. PubMed ID: 33757771
[TBL] [Abstract][Full Text] [Related]
57. [Current status and perspective of research on PEG-PLGA].
Zhou HN; Li YM; Liu T
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):561-3. PubMed ID: 21122404
[No Abstract] [Full Text] [Related]
58. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells.
Tran TH; Nguyen TD; Van Nguyen H; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Arch Pharm Res; 2016 May; 39(5):687-94. PubMed ID: 27015824
[TBL] [Abstract][Full Text] [Related]
59. Targeting intracellular compartments by magnetic polymeric nanoparticles.
Kocbek P; Kralj S; Kreft ME; Kristl J
Eur J Pharm Sci; 2013 Sep; 50(1):130-8. PubMed ID: 23603023
[TBL] [Abstract][Full Text] [Related]
60. Impact of PEG and PEG-b-PAGE modified PLGA on nanoparticle formation, protein loading and release.
Rietscher R; Czaplewska JA; Majdanski TC; Gottschaldt M; Schubert US; Schneider M; Lehr CM
Int J Pharm; 2016 Mar; 500(1-2):187-95. PubMed ID: 26784983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
